tiprankstipranks
Trending News
More News >
Quantum Biopharma (TSE:QNTM)
:QNTM
Canadian Market

Quantum Biopharma (QNTM) Income Statement

Compare
80 Followers

Quantum Biopharma Income Statement

Last quarter (Q4 2023), Quantum Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Quantum Biopharma's net income was $―. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Aug 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 4.54M$ 4.11M$ 3.90M$ ―
EBITDA
$ ―$ -22.57M$ -29.09M$ -24.46M$ -19.37K
Operating Income
$ -19.23M$ -27.48M$ -33.81M$ -30.69M$ -19.37K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Quantum Biopharma Earnings and Revenue History